Last week, the foundation made its biggest such investment, a $52 million equity stake in CureVac, a biopharmaceutical company that is working on technology that could produce vaccines faster, cheaper and more effectively. The foundation wants to ensure that the technology can be put to work preventing diseases that disproportionately affect the world’s poor, Ms. Max writes.The foundation ‒ which now has $1.5 billion on hand for loans, equity investments and volume guarantees ‒ has also used program-related investments in areas like education, agriculture and financial services for the poor. Last year, for instance, the foundation invested $11 million in bKash, which lets users turn a mobile phone into a means of storing and transferring money.Advertisement